ALX Oncology (ALXO) Stock Chart & Stock Price History $1.45 +0.02 (+1.40%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ALX Oncology Stock Price Performance5 Day Performance-0.68%1 Month Performance-20.77%3 Month Performance-49.30%6 Month Performance-91.28%Year-To-Date Performance-90.26%1 Year Performance-81.17% Receive ALXO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. ALXO Stock Chart for Saturday, November, 2, 2024 ALXO Chart by TradingView ALX Oncology Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$1.43$1.45+1.40%$1.52$1.40740,794 shs$76.37 million10/31/2024$1.38$1.43+3.62%$1.47$1.341.09 million shs$75.32 million10/30/2024$1.40$1.38-1.43%$1.44$1.361.04 million shs$72.69 million10/29/2024$1.46$1.40-4.11%$1.53$1.37979,434 shs$72.94 million10/28/2024$1.47$1.46-0.68%$1.53$1.43792,786 shs$76.07 million10/25/2024$1.46$1.47+1.03%$1.51$1.46292,887 shs$76.59 million Get the Latest News and Ratings for ALXO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$1.66$1.46-12.35%$1.67$1.45822,976 shs$75.81 million10/23/2024$1.50$1.66+10.67%$1.77$1.461.28 million shs$86.49 million10/22/2024$1.50$1.50$1.57$1.461.85 million shs$78.15 million10/21/2024$1.48$1.50+1.35%$1.56$1.43637,384 shs$78.15 million10/18/2024$1.51$1.48-1.99%$1.51$1.45327,627 shs$77.11 million10/17/2024$1.56$1.51-3.21%$1.57$1.48752,020 shs$78.67 million10/16/2024$1.56$1.56$1.61$1.55588,682 shs$81.28 million10/15/2024$1.55$1.56+0.65%$1.58$1.52385,831 shs$81.28 million10/14/2024$1.54$1.55+0.65%$1.61$1.50316,953 shs$80.76 million10/11/2024$1.44$1.54+6.94%$1.55$1.44560,189 shs$81.11 million10/10/2024$1.62$1.44-11.11%$1.61$1.42623,899 shs$75.02 million10/09/2024$1.65$1.62-1.82%$1.68$1.59269,383 shs$84.40 million10/08/2024$1.59$1.65+3.77%$1.67$1.58288,404 shs$85.97 million10/07/2024$1.68$1.59-5.36%$1.69$1.56393,076 shs$82.84 million10/04/2024$1.72$1.68-2.33%$1.74$1.64371,570 shs$87.53 million10/03/2024$1.83$1.72-6.01%$1.83$1.68594,098 shs$89.61 million10/02/2024$1.86$1.83-1.61%$1.93$1.81483,786 shs$95.34 million10/01/2024$1.82$1.86+2.20%$1.91$1.77544,163 shs$96.91 million09/30/2024$1.97$1.82-7.61%$1.99$1.77607,831 shs$94.82 million09/27/2024$1.87$1.97+5.35%$2.01$1.88506,813 shs$103.76 million09/26/2024$1.81$1.87+3.31%$1.88$1.76496,724 shs$98.49 million09/25/2024$1.95$1.81-7.18%$1.94$1.79644,744 shs$95.33 million09/24/2024$1.99$1.95-2.01%$2.06$1.87537,586 shs$101.60 million09/23/2024$2.07$1.99-3.86%$2.08$1.93646,529 shs$103.68 million09/20/2024$2.17$2.07-4.61%$2.22$2.06887,990 shs$107.85 million09/19/2024$2.14$2.17+1.40%$2.26$2.14401,614 shs$113.06 million09/18/2024$2.18$2.14-1.83%$2.26$2.13389,219 shs$111.49 million09/17/2024$2.18$2.18$2.22$2.14423,296 shs$113.58 million09/16/2024$2.22$2.18-1.80%$2.36$2.16427,994 shs$113.58 million09/13/2024$2.14$2.22+3.74%$2.22$2.16235,064 shs$116.93 million09/12/2024$2.18$2.14-1.83%$2.24$2.12231,907 shs$111.49 million09/11/2024$2.16$2.18+0.93%$2.19$2.10261,017 shs$113.58 million09/10/2024$2.10$2.16+2.86%$2.19$2.01708,488 shs$112.54 million09/09/2024$1.91$2.10+9.95%$2.10$1.89620,053 shs$110.61 millionWhy Buffett, Bezos, & Congress Are Piling Into This One Sector (Ad)Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details09/06/2024$1.99$1.91-4.02%$2.01$1.88746,409 shs$99.51 million09/05/2024$2.06$1.99-3.40%$2.11$1.97541,770 shs$103.68 million09/04/2024$2.14$2.06-3.74%$2.20$2.02790,458 shs$108.50 million09/03/2024$2.32$2.14-7.76%$2.31$2.08668,117 shs$112.71 million09/02/2024$2.32$2.32$2.37$2.24860,700 shs$122.19 million08/30/2024$2.30$2.32+0.87%$2.37$2.25860,688 shs$120.87 million08/29/2024$2.34$2.30-1.71%$2.42$2.30430,468 shs$119.83 million08/28/2024$2.49$2.34-6.02%$2.49$2.30633,968 shs$121.91 million08/27/2024$2.57$2.49-3.11%$2.57$2.42702,235 shs$129.73 million08/26/2024$2.39$2.57+7.53%$2.59$2.32951,553 shs$133.90 million08/23/2024$2.33$2.39+2.58%$2.48$2.34742,634 shs$124.52 million08/22/2024$2.50$2.33-6.80%$2.57$2.301.16 million shs$121.39 million08/21/2024$2.51$2.50-0.40%$2.60$2.46642,957 shs$130.25 million08/20/2024$2.57$2.51-2.33%$2.73$2.49874,824 shs$130.77 million08/19/2024$2.54$2.57+1.18%$2.66$2.50863,703 shs$133.90 million08/16/2024$2.65$2.54-4.15%$2.73$2.53837,615 shs$132.33 million08/15/2024$2.58$2.65+2.71%$2.79$2.561.42 million shs$138.07 million08/14/2024$2.64$2.58-2.27%$2.77$2.521.54 million shs$134.42 million08/13/2024$2.52$2.64+4.76%$2.66$2.461.02 million shs$137.54 million08/12/2024$2.61$2.52-3.45%$2.64$2.421.54 million shs$131.29 million08/09/2024$2.63$2.61-0.76%$2.75$2.491.58 million shs$135.98 million08/08/2024$2.57$2.63+2.33%$2.69$2.451.50 million shs$137.02 million08/07/2024$2.75$2.57-6.55%$2.75$2.501.84 million shs$133.90 million08/06/2024$2.73$2.75+0.73%$2.80$2.601.22 million shs$143.28 million08/05/2024$2.86$2.73-4.55%$2.89$2.502.10 million shs$142.23 million08/02/2024$2.80$2.86+2.14%$3.02$2.513.27 million shs$149.01 million08/01/2024$4.80$2.80-41.67%$3.48$2.7210.79 million shs$145.88 million Related Companies Sutro Biopharma Stock Chart Inozyme Pharma Stock Chart UroGen Pharma Stock Chart Atea Pharmaceuticals Stock Chart ProQR Therapeutics Stock Chart Genfit Stock Chart ChromaDex Stock Chart Opthea Stock Chart Heron Therapeutics Stock Chart Editas Medicine Stock Chart Receive ALXO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ALX Oncology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALXO) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ALXO Stock Alerts